Nov 05,2018

AI In Dermatology: Future Implications

The rapid progress in machine learning, modern algorithms have been designed with the ability to choose their own “learning strategies”, much like a human being would. In the field of dermatology, machines trained with a wide range and number of dermoscopic images have proven successful in identifying skin cancer lesions. This specially designed algorithm was shown to provide similar accuracy to a group of selected physicians, some of them with years of experience.

#ai/software

#ml

View Analyst & Ambassador Comments
Go to original news
Nov 29,2018

How Is AI Changing SaaS In Dermatology?

Dermatology practices have been witness to rapid changes in technology for optimized care. The increased connectivity caused by widespread internet networks has allowed for the implementation of cloud services with remote accessibility, known as software as a service (SaaS) systems. This article will review the increasing expansion of SaaS in healthcare and how AI is set to make them more efficient and interoperable platforms for improved skin care services.

#ai/software

View Analyst & Ambassador Comments
Go to original news
Nov 12,2018

Government and Philips Consortium Co-Invest in Digital Pathology and AI Innovation to Improve Cancer Care in the UK

Royal Philips has been leading two healthcare innovation projects that will receive government investment as part of major cross-sector collaborations with the NHS, academia and industry partners from the Government's Industrial Strategy Challenge Fund, delivered through United Kingdom Research and Innovation (UKRI). Philips will be the principal partner on major cross-sector collaboration project PathLAKE (Pathology image data Lake for Education, Analytics and Discovery) which has received £10m of government funding to develop innovative AI in pathology.

COLLABORATION PARTNERSHIP

#r&d

#ai/software

View Analyst & Ambassador Comments
Go to original news
Nov 27,2018

AI System may Accelerate Search for Cancer Discoveries

Searching through the mountains of published cancer research could be made easier for scientists, thanks to a new AI system. The system, called LION LBD and developed by computer scientists and cancer researchers at the University of Cambridge, has been designed to assist scientists in the search for cancer-related discoveries. It is the first literature-based discovery system aimed at supporting cancer research. The results are reported in the journal Bioinformatics.

CLINICAL STUDY

#ai/software

View Analyst & Ambassador Comments
Go to original news
Nov 21,2018

Syntropy to Unlock the Value of Scientific Data in Fight to End Cancer

Merck and software company Palantir Technologies, today announced their intent to form a joint venture under the brand name Syntropy. Research institutions around the world are generating a rapidly growing amount of biomedical data, but much of it is trapped in silos within and between institutions. Today, this critical data is often inaccessible to the scientists and clinicians who need it to advance their work. Syntropy aims to unlock the value of this untapped data, enabling the world's leading experts to collaborate in the fight against cancer and many other diseases.

COLLABORATION PARTNERSHIP

#product & service

#rwd

View Analyst & Ambassador Comments
Go to original news
Nov 02,2018

Novartis data at ASH and SABCS show strength of pipeline and portfolio in hematology and oncology

Novartis will present new research that may transform the way serious blood diseases and a certain type of breast cancer are treated at the upcoming 60th American Society of Hematology (ASH) Annual Meeting & Exposition in San Diego, December 1-4 and the 41st Annual San Antonio Breast Cancer Symposium (SABCS), December 4-8. Nearly 150 abstracts will be presented across both congresses, underscoring the strength of the Novartis pipeline and portfolio in hematology and oncology.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Oct 17,2018

What Features Are Dermatologists Looking For In Their Dermatoscope?

Dermoscopy is becoming common practice in dermatology services, as magnified skin imaging proves to increase diagnosis accuracy and reduce unnecessary biopsies. However, before a dermatologist can begin utilizing a dermoscope, he must determine which technical characteristics will best suit his imaging needs. This article will present an overview of the current status of dermoscopy while comparing features of mobile dermoscopes.

PRODUCT

#connected device

#telehealth

View Analyst & Ambassador Comments
Go to original news
Oct 26,2018

International Certificate of Dermatoscopy and Skin Cancer Medicine in Oxford

MetaOptima is excited to announce its sponsorship of the International Certificate of Dermatoscopy and Skin Cancer Medicine event held October 27th-28th in Oxford, UK. As part of this initiative, the Company announced that every member will be receiving a complimentary 1-year subscription to DermEngine (intelligent dermatology software) and a free MoleScope II (mobile dermoscope)!

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Oct 23,2018

What Are The Top 7 Dermoscopy Features You Need To Know?

Dermoscopy use in dermatology has been on the rise in the last decade due to its practical advantages for the diagnosis of skin conditions.1 Statistics show that dermoscopy has the potential to outperform traditional methods for skin lesion examination in efficacy (melanoma detection) and unnecessary biopsies reduction. This article summarizes the top seven features from MetaOptima's DermEngine that are driving the latest trends in dermoscopy as a crucial component of modern dermatology services.

PRODUCT

#ai/software

#connected device

View Analyst & Ambassador Comments
Go to original news
Oct 18,2018

How Are BC’s Supercluster Companies Supporting The Canadian Economy?

MetaOptima is excited to announce its partnership with Change Healthcare to develop and implement an intelligent dermatology software network with the support of DermEngine and MoleScope for improved patient care across Canada. In February of 2018, British Columbia was announced as the home of one of five superclusters across Canada. MetaOptima and a select few other visionary organizations (BC Cancer Agency, TELUS Health, Providence Health Care, Careteam, and the University of Victoria) have been provided with the opportunity to revolutionize the Canadian healthcare industry with an intelligent framework for providing quality patient care.

COLLABORATION PARTNERSHIP

#r&d

#ai/software

#telehealth

View Analyst & Ambassador Comments
Go to original news
Subscribe to ONCOLOGY